Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 21, 2026
TickeronGET DAILY SIGNALS
CME Group (CME) Reports Record Q3 Revenue and Volume Growth

CME Group (CME) Reports Record Q3 Revenue and Volume Growth

Key Takeaways

  • CME Group reported record third-quarter revenue of $1.74 billion, up 13% year over year.
  • Adjusted earnings per share (EPS) reached $3.02, up 13% and above the consensus estimate of $2.98.
  • Average daily volume (ADV) hit a record 29.4 million contracts, up 16%, with double-digit growth across all six asset classes.
  • Market data revenue climbed to an all-time record of $243 million, its 34th consecutive quarter of growth.
  • The company returned roughly $1 billion to shareholders through dividends and buybacks.

Why These Results Matter in the Current Market Environment

CME Group operates some of the world's largest derivatives exchanges and serves as a central venue for managing risk across interest rates, equities, currencies, energy, metals, and agriculture. Its results act as a barometer for global trading activity, since higher volatility and shifting central-bank policy tend to drive more volume through its platforms. The third quarter of 2026 took place against a backdrop of persistent geopolitical uncertainty and market volatility, conditions that historically favor increased hedging activity. This report therefore matters not only for CME shareholders but also for investors seeking a read on the health of global capital markets heading into year-end.

Breaking Down the Reported Figures

CME Group reported total revenue of $1.74 billion for the quarter ended September 30, 2026, up 13% from $1.54 billion a year earlier and the highest third-quarter revenue in company history. Clearing and transaction fees rose to $1.38 billion, while market data and information services revenue climbed 20% to a record $243 million.

Adjusted diluted EPS came in at $3.02, up 13% year over year and above the consensus estimate of $2.98. Adjusted operating income reached $1.2 billion, up 15%, translating to a 69.4% adjusted operating margin. On a GAAP basis, net income was $1.04 billion, with diluted EPS of $2.89.

The standout driver was volume. Average daily volume (ADV) reached a record 29.4 million contracts, up 16%, with double-digit growth across every asset class. Equity products led the way, up 23%, and international ADV grew 22% to a record 9 million contracts per day. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Market Reaction and Investor Sentiment

The results were widely viewed as a beat, with revenue and adjusted EPS both surpassing consensus estimates by roughly 1% to 1.4%. Investor attention focused less on the modest beat and more on the breadth of the growth: double-digit volume increases in every asset class and record open interest, which reached 128 million contracts at quarter-end and has since exceeded 133 million. Management's disclosure that fourth-quarter volume was tracking 17% above the prior year's record reinforced the view that momentum is carrying into the current period. Sentiment also benefited from disciplined capital returns, with nearly $1 billion distributed to shareholders during the quarter.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors will watch whether CME Group can sustain its volume momentum into year-end. Management noted that fourth-quarter average daily volume was running 17% ahead of last year's record quarter and that full-year volume was tracking 12% ahead of the prior record, pointing to the potential for another record year.

A key catalyst on the horizon is the scheduled December launch of CME Securities Clearing, ahead of the SEC's Treasury clearing mandate. This expansion into securities clearing represents a new growth avenue that could diversify revenue beyond traditional futures and options clearing.

Other factors worth monitoring include the pace of the company's cloud migration with Google Cloud, which is expected to begin moving markets in late 2027, and license-fee costs tied to equity volume. Margin and capital-efficiency dynamics will also matter, as interest-rate levels influence investment income from cash held at the clearing house. As always, sustained volatility and hedging demand across global markets will remain the core driver of CME Group's top-line performance. From what I see, the breadth of growth across asset classes suggests the momentum could hold if volatility persists.

Exploring AI Tools in My Research Process

I often turn to Tickeron’s AI-powered tools when analyzing earnings reports like this one. The AI Screener helps me quickly filter stocks and ETFs by technical patterns, fundamentals, and performance metrics, making it easier to compare opportunities across sectors and identify patterns that might otherwise take hours to spot manually. It has become a regular part of how I cross-check volume trends and peer performance before forming a fuller view.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CME

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CME saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for CME moved out of overbought territory on November 18, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 68 similar instances where the indicator exited the overbought zone. In 30 of the 68 cases the stock moved lower. This puts the odds of a downward move at 44%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CME moved out of overbought territory on November 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 16 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 40%.

The Moving Average Convergence Divergence Histogram (MACD) for CME turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 19 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 41%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CME declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 20, 2026. You may want to consider a long position or call options on CME as a result. In 64 of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.

Following a +1.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where CME advanced for three days, in 174 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.

The Aroon Indicator entered an Uptrend today. In 137 of 259 cases where CME Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 53%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 31 (best 1 - 100 worst), indicating outstanding price growth. CME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 32 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 50 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.147) is normal, around the industry mean (4.143). P/E Ratio (25.814) is within average values for comparable stocks, (19.659). CME's Projected Growth (PEG Ratio) (4.578) is very high in comparison to the industry average of (1.780). Dividend Yield (0.017) settles around the average of (0.017) among similar stocks. CME's P/S Ratio (14.535) is slightly higher than the industry average of (7.166).

Notable companies

The most notable companies in this group are CME Group (NASDAQ:CME).

Industry description

The financial publishing /services sector includes companies that provide informational products and services that are of value to investors, financial/analytics professionals and other interested readers. The products include real-time stock quotes, financial news and analyses. Think S&P Global, Inc., Moody`s Corporation, Thomson-Reuters Corp and IHS Markit Ltd. Information is critical in making financial or investment decisions, and what makes this industry’s output relevant at all times, across various economic conditions.

Market Cap

The average market capitalization across the Financial Publishing/Services Industry is 46.28B. The market cap for tickers in the group ranges from 1.27M to 137.91B. SPGI holds the highest valuation in this group at 137.91B. The lowest valued company is BTOG at 1.27M.

High and low price notable news

The average weekly price growth across all stocks in the Financial Publishing/Services Industry was -7%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 3%. DTCX experienced the highest price growth at 3%, while COIN experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the Financial Publishing/Services Industry was 56%. For the same stocks of the Industry, the average monthly volume growth was 10% and the average quarterly volume growth was 7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 80
P/E Growth Rating: 49
Price Growth Rating: 44
SMR Rating: 52
Profit Risk Rating: 75
Seasonality Score: 30 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator of securities and commodity exchanges

Industry FinancialPublishingServices

Industry
Investment Banks Or Brokers
Address
20 South Wacker Drive
Phone
+1 312 930-1000
Employees
3875
Web
https://www.cmegroup.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.